Search

Synovial sarcoma is an aggressive cancer primarily affecting children and young adults. A new study gets to the bottom of it.

… Thursday, March 1, 2018 Summary A new study deciphers the molecular cause of an aggressive cancer primarily affecting children and young adults. Researchers at the Sloan Kettering Institute have unraveled how a genetic mutation drives a type of aggressive soft tissue cancer called synovial sarcoma .

Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine.

… Monday, December 14, 2020 Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine, according to a retrospective analysis of patients treated at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center (MSK) and Miami Cancer Institute at Baptist Health South Florida announce the beginning of a dynamic and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and the highest caliber of cancer care. Leaders from both institutions have confirmed the first step in announcing their recently signed agreement for Miami Cancer Institute to join the Memorial Sloan Kettering Cancer Alliance.

… Wednesday, February 10, 2016 Memorial Sloan Kettering Cancer Center (MSK) and Miami Cancer Institute at Baptist Health South Florida announce the beginning of a dynamic and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and

The summer programs connect high school and medical school students with MSK faculty while offering the opportunity for student-to-student mentorship.

… Thursday, October 6, 2022 At the end of the summer, Memorial Sloan Kettering Cancer Center (MSK) concluded two of its annual research programs for students. Twenty medical school students completed the Summer Pipeline Program and 15 New York City high school students completed the Summer Exposure Program

The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012.

… Thursday, October 4, 2018 The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012. Unlike

A number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I studies are already demonstrating dramatic results.

… Saturday, December 6, 2014 In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. Studies presented today at the 56th Annual Meeting of the American Society of Hematology (ASH) highlight the

Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.

… Monday, November 30, 2020 Summary Tumors with mutations in the BRCA2 cancer-predisposition gene respond better to checkpoint blockade immunotherapy than tumors with mutations in BRCA1 , scientists at Memorial Sloan Kettering have found. Treatments that harness the immune system to fight cancer have greatly

Fighting cancer is often sobering and difficult work, but it is also full of hope. Ask anyone who works at MSK what inspires them, and they will tell you it’s the courage and resilience of the people they care for every day.

… Thursday, September 11, 2025 Dear MSK Community, If you ask the 21,000 people who work at MSK what inspires their tireless commitment to our mission of ending cancer for life, you will hear remarkable responses. Stories about the courage and resilience of the people we care for, an epiphany early in

… Friday, June 6, 2025 From the day Shakima Grant was hired as a care coordinator at MSK, in 2007, she says she knew she had found her purpose. “It always felt like I was meant to be here,” says Shakima, whose grandmother passed away from stage 4 ovarian cancer that very same year. Her grandmother lived

What's it like being LGBTQ in the world of science? We asked some MSK scientists to find out.

… Thursday, June 21, 2018 From left: Jason Lewis, Scott Keeney, Kat Hadjantonakis, Stefanie Windner, and Suleman Hussain. From left: Jason Lewis, Scott Keeney, Kat Hadjantonakis, Stefanie Windner, and Suleman Hussain. Photos by Rick DeWitt. They’re here. They’re queer. They’re scientists. In honor of Pride